BIO Asia–Taiwan 2025 亞洲生技大會

BIO Asia–Taiwan 2025 亞洲生技大會

講師

Edward Hsieh

​​


Session 4 – ADC Drug development and manufacturing trends challenges and solutions

Date:24 July (Wednesday)
Time15:15– 15:40 (GMT+8)

Edward Hsieh

Vice President
​Formosa Laboratories Inc.

​​

Education
B. Sc., Department of Chemistry/National Taiwan University
M. Sc. Department of Chemistry/Simon Fraser University, Canada
Ph. D. Department of Chemistry/Simon Fraser University, Canada
Multidisciplinary Management of Technology (MMOT)/National ChengChi University
EMBA program/National Taiwan University

Work Experience
Current position and status
Formosa Laboratories Inc. Jul. 2021-
Position: Vice President, R&D department
Taiwan Accreditation Foundation External reviewer
TFDA Chinese Pharmacopeia Committee Committee Member July, 2016-

Previous positions
1. OBI Pharma. Inc. Associate Director, Director, CMC department
2. Center for Drug Evaluation. Researcher/CMC Reviewer/DMF Team leader
3. Ningbo Smart Pharmaceutical Company. Vice President
4. Industrial Technology Research Institute (ITRI) Researcher
5. Post-doctoral research

Other Achievements

  • Negotiation strategies and simulation, Aug. 30th and Sep. 4th, 2011, Taiwan Food and Drug Administration.
  • Policy negotiation representative of TFDA with SFDA/CDE China, 2011/09/18~09/25, 2012/04/22~04/28
  • USFDA/PDA Joint Conference and training course, Process validation, 2012/10/22~26.

Lectures:
Invited to 14 conferences/lecture as guess speaker across Taiwan, China and Canada.

Patent
4 PCT patent granted

Scientific Publications
11 Scientific publications on various international journals
 

Speech title & Synopsis

Panel Discussion
​.

​​